New technology for patients with cardiac arrhythmias in Quebec
The McGill University Health Centre (MUHC) will offer a new pulse field ablation as a minimally invasive procedure to treat atrial fibrillation, the most common form of cardiac arrhythmia.
According to a press release, this will be the first health centre in Quebec to offer this new technology, which is safer than the standard catheter ablation and more efficient.
It could also help to diminish the waiting lists for this procedure.
“We are pleased to be able to provide our patients with the highest quality of care by making the latest technologies available to our professionals. This would not have been possible without the multidisciplinary collaboration of the MUHC teams,” said Director of the MUHC Division of Cardiology Dr. Atul Verma.
A clinical study led by Dr. Verma evaluated the safety and efficacy of Medtronic’s PulseSelectTM pulsed field ablation (PFA) system.
The results of the trial were published in March